Was the CBS 60 Minutes special on stem cells wrong?
Local Group Says Stem Cell Regeneration Worked For Themposted January 16, 2012
The CBS 60 Minutes broadcast on Sunday, Jan. 8, exposed shysters selling dead stem cells for $5,000, who falsely promised cures with these stem cells, but members of a local group said stem cell regeneration has worked for them.
“Unfortunately 60 Minutes failed to report the bigger exciting news on stem cells,” said Chattanooga resident Mary Alice Crápo, a member of adultstemcellfoundation.org and board member of 4CHEO.org, the Complimentary Health Educational Organization in Chattanooga.
She said, “The 60 Minutes broadcast lead viewers to believe that all stem cell therapy is fraud. What the public needs to know is that there are at least three natural products available that enable adults to increase their own adult stem cells.”
She said on July 30, 2011, she began adult stem cell enhancement which meant taking four capsules every morning. “In five weeks, it was obvious I no longer would need a cornea transplant. Dr. Izak Wessels, my eye surgeon, was impressed about the improvement of my vision especially my chronic dry eye in five weeks on adult stem cell stimulation. Five months later both of my eyes that suffered with chronic dry eye are producing tears off the top of the chart.”
She said Dan Robinson in Texas fell 30 feet 20 years ago. He states, “My entire body has regenerated in six months on a stem cell enhancement. I want to shout it to the mountain tops. After 22 years of suffering, I am 90 percent pain free. This year I can walk without stumbling and have improved from head to toe.”
Mrs. Crapo said, "So many people are experiencing major health rejuvenation with adult stem cell stimulation. The other side of the CBS 60 Minutes story needs to be told since it is an established medical fact that stem cells can rebuild a kidney, heart, liver, brain, joint, lung, vision and can basically rebuild any soft tissue in the body.
"The exciting news is that expensive costly surgeries to implant these stem cells aren’t necessary if you provide the ingredients or tools the body needs to make these amazing cells naturally.
There will be a meeting Monday, Jan. 23, at 6:30 p.m. at the Glass Building attached to the Village Market in Collegedale. On hand will be "first-person accounts from those who have already experienced amazing results with stem cell enhancement," she said.
Allan Fontenot from Cleveland, Tn., will be there to share his story. She said, "Allan’s eyes did not track together from birth until this year. Find out how adult stem cells changed his life and there will be others there as well sharing their stories."
see the adult stem cell foundation org website
Showing posts with label foetal stem cells. Show all posts
Showing posts with label foetal stem cells. Show all posts
Wednesday, January 18, 2012
Monday, October 31, 2011
Stem cells used to regenerate lungs?
Stem cells used to regenerate lungs?
Working together, scientists and clinicians make research breakthrough that paves the way for novel therapies for respiratory diseases
"We have harvested these "pods" to provide insight into genes and secreted factors that likely represent key components in tissue regeneration.
These secreted factors might be used as biological drugs (biologics) to enhance regeneration of the lung and airways," said Dr Frank McKeon, Senior Group Leader of the Stem Cell and Developmental Biology at GIS.
The research was jointly led by Dr Frank McKeon from GIS and Dr Wa Xian from IMB in collaboration with scientists at the National University of Singapore (NUS), and clinicians at the Harvard Medical School and the Brigham and Women's Hospital in Boston.
Prof Birgitte Lane, Executive Director of IMB, said, "This groundbreaking work is a fine example of collaborative research, which has brought us new insight into lung epithelial stem cells. This will have breakthrough consequences in many areas." Dr Edison Liu, Executive Director of GIS, added, "We will continue to seek impactful collaborations and build upon this research area where there is a need for novel therapies, which will offer hope for patients suffering from respiratory diseases."
click to read more on this adance in lung therapy in lung regeneration
Working together, scientists and clinicians make research breakthrough that paves the way for novel therapies for respiratory diseases
Scientists at A*STAR'S Genome Institute of Singapore (GIS) and Institute of Molecular Biology (IMB), have made a breakthrough discovery in the understanding of lung regeneration. Their research showed for the first time that distal airway stem cells (DASCs), a specific type of stem cells in the lungs, are involved in forming new alveoli to replace and repair damaged lung tissue, providing a firm foundation for understanding lung regeneration.
Lung damage is caused by a wide range of lung diseases including influenza infections and chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD). Influenza infection induces acute respiratory distress syndrome (ARDS) which affects more than 150,000 patients a year in the US, with a death rate of up to 50 percent. COPD is the fifth biggest killer worldwide.
The team took a novel approach in tackling the question of lung regeneration. They cloned adult stem cells taken from three different parts of the lungs - nasal epithelial stem cells (NESCs), tracheal airway stem cells (TASCs) and distal airway stem cells (DASCs). Despite the three types of cells being nearly 99 percent genetically identical, the team made the surprising observation that only DASCs formed alveoli when cloned in vitro.
"We are the first researchers to demonstrate that adult stem cells are intrinsically committed and will only differentiate into the specific cell type they originated from. In this case, only DASCs formed alveoli because alveolar cells are found in the distal airways, not in the nasal epithelial or tracheal airway", said Dr Wa Xian, Principal Investigator at IMB. "This is a big advancement in the understanding of adult stem cells that will encourage further research into their potential for regenerative medicine."
Using a mouse model of influenza, the team showed that after infection, DASCs rapidly grow and migrate to influenza-damaged lung areas where they form "pods". These "pods" mature to new alveoli which replace the alveoli that were destroyed by the infection, leading to lung regeneration.
Lung damage is caused by a wide range of lung diseases including influenza infections and chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD). Influenza infection induces acute respiratory distress syndrome (ARDS) which affects more than 150,000 patients a year in the US, with a death rate of up to 50 percent. COPD is the fifth biggest killer worldwide.
The team took a novel approach in tackling the question of lung regeneration. They cloned adult stem cells taken from three different parts of the lungs - nasal epithelial stem cells (NESCs), tracheal airway stem cells (TASCs) and distal airway stem cells (DASCs). Despite the three types of cells being nearly 99 percent genetically identical, the team made the surprising observation that only DASCs formed alveoli when cloned in vitro.
"We are the first researchers to demonstrate that adult stem cells are intrinsically committed and will only differentiate into the specific cell type they originated from. In this case, only DASCs formed alveoli because alveolar cells are found in the distal airways, not in the nasal epithelial or tracheal airway", said Dr Wa Xian, Principal Investigator at IMB. "This is a big advancement in the understanding of adult stem cells that will encourage further research into their potential for regenerative medicine."
Using a mouse model of influenza, the team showed that after infection, DASCs rapidly grow and migrate to influenza-damaged lung areas where they form "pods". These "pods" mature to new alveoli which replace the alveoli that were destroyed by the infection, leading to lung regeneration.
"We have harvested these "pods" to provide insight into genes and secreted factors that likely represent key components in tissue regeneration.
These secreted factors might be used as biological drugs (biologics) to enhance regeneration of the lung and airways," said Dr Frank McKeon, Senior Group Leader of the Stem Cell and Developmental Biology at GIS.
The research was jointly led by Dr Frank McKeon from GIS and Dr Wa Xian from IMB in collaboration with scientists at the National University of Singapore (NUS), and clinicians at the Harvard Medical School and the Brigham and Women's Hospital in Boston.
Prof Birgitte Lane, Executive Director of IMB, said, "This groundbreaking work is a fine example of collaborative research, which has brought us new insight into lung epithelial stem cells. This will have breakthrough consequences in many areas." Dr Edison Liu, Executive Director of GIS, added, "We will continue to seek impactful collaborations and build upon this research area where there is a need for novel therapies, which will offer hope for patients suffering from respiratory diseases."
click to read more on this adance in lung therapy in lung regeneration
Tuesday, September 21, 2010
When you need new lungs
When you need new lungs!
September 21, 2010
People with terminal lung disease may find solace in the recent breakthroughs made in the stem cell research.
Scientists at the Harvard Medical School and Yale University have grown artificial lungs that work in rats using stem cells.
Presently, a lung transplant is the only option for people with terminal lung disease caused by smoking or conditions like cystic fibrosis. However, donor organs are in short supply and rejection is likely even if a lung is available.
To solve both these issues, the researchers stripped original tissue of the donor lungs. The teams then repopulated the remaining connective tissue with foetal stem cells and helped the organs grow.
http://wonderwoman.intoday.in/wonderwoman/story/86607/Health/when-you-need-new-lungs!.html
September 21, 2010
People with terminal lung disease may find solace in the recent breakthroughs made in the stem cell research.
Scientists at the Harvard Medical School and Yale University have grown artificial lungs that work in rats using stem cells.
Presently, a lung transplant is the only option for people with terminal lung disease caused by smoking or conditions like cystic fibrosis. However, donor organs are in short supply and rejection is likely even if a lung is available.
To solve both these issues, the researchers stripped original tissue of the donor lungs. The teams then repopulated the remaining connective tissue with foetal stem cells and helped the organs grow.
http://wonderwoman.intoday.in/wonderwoman/story/86607/Health/when-you-need-new-lungs!.html
Subscribe to:
Posts (Atom)